Skip to content

Clinical trials

Schizophrenia trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: South Africa Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20046
20052
20062
20073
20085
20091
20103
20112
20121
20131
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
AstraZeneca4
Sumitomo Pharma America, Inc.4
Janssen-Cilag International NV3
Janssen Research & Development, LLC2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Denovo Biopharma LLC1
Eli Lilly and Company1
Forest Laboratories1
Janssen Cilag N.V./S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia29
Psychotic Disorders5
Bipolar Disorder1
Body Weight Changes1
Dyskinesias1
Mental Disorders1
Recurrence1
Tardive Dyskinesia1

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.